Lilly’s Case Against Mochi Moves Forward, and the Fight Over Compounded Tirzepatide Is Getting Bigger
As GLP-1 care becomes a consumer market, who gets to draw the lines?
On The Pen | GLP-1 & Obesity Medicine News
On The Pen Patient Tool
Find My Trial
Find obesity and metabolic clinical trials that may be relevant to you, then connect directly with the study team when contact information is available.
Find My Trial2,478 recruiting studies tracked across 418 treatments — sourced from ClinicalTrials.gov.
Top Stories
The most-read On The Pen stories, ranked by reader engagement.
Novo Nordisk Just Changed the Childhood Obesity Conversation
New data helps to bolster the case for early pharmacologic obesity interventions.
Latest News
I Was Selling Traffic Signals. Then Everything Changed.
I’ve Never Told This Part of the On The Pen Story
The Weekly Dose
On The Pen's flagship podcast — obesity medicine, unfiltered.
Recent Livestreams
Obesity.News
Stay ahead of obesity medicine.
Breaking GLP-1 news, drug development, access updates, and patient-centered analysis, all in one place.
- Breaking obesity medicine and GLP-1 news
- The latest from The Weekly Dose podcast
- Live talk show every Monday, Wednesday, and Friday at 11 AM CT
- Deeper reporting and analysis for paid subscribers
Empowering you to have better conversations with your doctor.
On The Pen covers obesity medicine from the patient's side of the exam table — GLP-1s, access, and the science, reported plainly.
Sponsors & Partners